1. Home
  2. WHD vs VKTX Comparison

WHD vs VKTX Comparison

Compare WHD & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cactus Inc.

WHD

Cactus Inc.

HOLD

Current Price

$58.15

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$32.79

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHD
VKTX
Founded
2011
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.3B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
WHD
VKTX
Price
$58.15
$32.79
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$56.33
$95.86
AVG Volume (30 Days)
664.8K
2.1M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
1.00%
N/A
EPS Growth
18.99
N/A
EPS
0.19
N/A
Revenue
$1,079,051,000.00
N/A
Revenue This Year
$43.92
N/A
Revenue Next Year
$6.83
N/A
P/E Ratio
$305.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.30
$22.96
52 Week High
$64.30
$43.15

Technical Indicators

Market Signals
Indicator
WHD
VKTX
Relative Strength Index (RSI) 52.66 56.83
Support Level $55.80 $29.32
Resistance Level $58.53 $36.56
Average True Range (ATR) 1.90 1.24
MACD -0.17 0.34
Stochastic Oscillator 38.94 93.00

Price Performance

Historical Comparison
WHD
VKTX

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: